All 2 tracked stories fall under one category: pharma. CMR Surgical is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across an 8-day span, the pace is roughly 1.8 stories per week. The 7.5 average consequence score is above the beat benchmark of 5.8 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about National Health Service (NHS)
All 2 tracked stories fall under one category: pharma. CMR Surgical is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across an 8-day span, the pace is roughly 1.8 stories per week. The 7.5 average consequence score is above the beat benchmark of 5.8 in the same window. They are better corroborated than the beat average, carrying 3.5 original sources each against 3.1 for the same window. National Health Service (NHS) appears in 2 tracked Biotech stories published from February 27, 2026 through March 6, 2026.
Stories tracked
2
Per week
1.8
Sources per story
3.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 73 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering National Health Service (NHS). Shared-story counts are live from our verified record — not editorial picks.
The United Kingdom has successfully completed its first remote robotic surgery, a historic achievement that bridges the gap between specialized surgical expertise and regional healthcare delivery. The procedure, conducted via a high-speed, low-latency network, marks a transformative moment for the NHS and the global medtech industry.
The UK government has unveiled a draft Rare Cancers Law designed to streamline the development and delivery of treatments for incurable brain tumors. This legislative framework aims to bridge the funding gap and accelerate clinical trial access for high-mortality, low-prevalence oncological conditions.
National Health Service (NHS) is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.